Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2013
10/01/2013CA2673924C Liposomal pharmaceutical preparation and method for manufacturing the same
10/01/2013CA2655901C Collagen product for medical or cosmetic applications, method for the manufacture thereof and use thereof
10/01/2013CA2642241C New stable hyperbaric composition comprising prilocaine hcl, use of said new composition for intrathecal anaesthesia, and method for manufacturing said composition
10/01/2013CA2632198C Pharmaceutical formulation containing phenytoin sodium and magnesium stearate
10/01/2013CA2628055C Polysaccharide-derived nitric oxide-releasing carbon-bound diazeniumdiolates
10/01/2013CA2625532C Agent for applying to mucosa containing a hydrophobic group binding type glycosaminoglycan
10/01/2013CA2615912C Lotion preparation containing pyridonecarboxylic acid derivative
10/01/2013CA2605839C Stabilized composition of a proton pump inhibitor
10/01/2013CA2573386C Composition for promoting vascular smooth muscle relaxation
10/01/2013CA2573245C Multivalent vla-4 antagonists comprising polymer moieties
10/01/2013CA2567532C Methods for making injectable polymer hydrogels
10/01/2013CA2563533C Compositions capable of facilitating penetration across a biological barrier
10/01/2013CA2522625C Magnetically controllable drug and gene delivery stents
10/01/2013CA2514510C Polymer conjugates of mutated neublastin
10/01/2013CA2507769C Density-controlled particulate suspensions for foodstuff, cosmetic, pharmaceutical and other uses
10/01/2013CA2433862C Molecular antigen array presenting amyloid beta
09/2013
09/28/2013CA2810911A1 Micronized starch and methods for manufacturing same
09/27/2013CA2784240A1 Stable bortezomib formulations
09/26/2013WO2013142792A1 Stabilizing composition for biological materials
09/26/2013WO2013142482A1 Gelling agent-based dosage form
09/26/2013WO2013142374A1 Compositions and uses of antimicrobial materials with tissue-compatible properties
09/26/2013WO2013142372A1 Targeted enzymatic degradation of quorum-sensing peptides
09/26/2013WO2013142255A2 Multi-specific binding agents
09/26/2013WO2013142251A1 Cyclodextrin-based microemulsions, and dermatological uses thereof
09/26/2013WO2013142249A1 Cyclodextrin-based microemulsions, and dermatological uses thereof
09/26/2013WO2013142247A1 Cyclodextrin-based microemulsions, and dermatological uses thereof
09/26/2013WO2013142135A1 Method of enhancing efficacy of blood transfusions
09/26/2013WO2013142119A1 Silk reservoirs for drug delivery
09/26/2013WO2013142088A1 Short antimicrobial lipopeptides
09/26/2013WO2013142034A1 Anti-mesothelin chimeric antigen receptors
09/26/2013WO2013141346A1 Method for producing liposome encapsulating paclitaxel monoglycoside and/or docetaxel monoglycoside
09/26/2013WO2013141267A1 Polyphenol stabilizer, and composition and processed goods containing said stabilizer
09/26/2013WO2013140799A1 Transdermal absorption preparation
09/26/2013WO2013140643A1 Carrier for intracellular delivery of functional protein
09/26/2013WO2013140317A2 Peptides
09/26/2013WO2013140265A2 Fertility enhancing agent
09/26/2013WO2013140222A1 Natural biocomposite powder prepared from pichia pastoris biomass, method of preparation and its use as excipient
09/26/2013WO2013140071A1 Cyclosporin a-based aqueous ophthalmic solution
09/26/2013WO2013139918A1 Topical application of ingenol mebutate with occlusion
09/26/2013WO2013139826A1 Pharmaceutical compositions comprising imatinib
09/26/2013WO2013139694A1 Compositions of glp-1 peptides and preparation thereof
09/26/2013WO2013139391A1 Novel photoimmunoconjugates for use in photodynamic therapy
09/26/2013WO2013139209A1 Topiramate sustained-release pharmaceutical composition, method for preparing same, and use thereof
09/26/2013WO2013138916A1 Multi-functional micro and nanoparticles for use in root canal therapies
09/26/2013WO2013073454A3 Controlled release composition for physiologically active substance
09/26/2013US20130253207 N-maleimidyl polymer derivatives
09/26/2013US20130253168 Novel single chemical entities and methods for delivery of oligonucleotides
09/26/2013US20130253135 Poly(amide) polymers for the delivery of oligonucleotides
09/26/2013US20130253073 Photocatalyst composition and preparation for the same
09/26/2013US20130253070 Combination of carotenoids and epi-lutein
09/26/2013US20130253055 Powderous formulations of fat-soluble active ingredients
09/26/2013US20130253042 Oligonucleotide Conjugates
09/26/2013US20130253015 Cyclodextrin-Based Microemulsions, and Dermatological Uses Thereof
09/26/2013US20130253014 Cyclodextrin-Based Microemulsions, and Dermatological Uses Thereof
09/26/2013US20130253009 Compositions for Drug Administration
09/26/2013US20130252998 Cci-779 formulations for parenteral administration
09/26/2013US20130252985 Flavoring Systems for Pharmaceutical Compositions and Methods of Making Such Compositions
09/26/2013US20130252945 Amorphous bioinorganic ionic liquid compositions comprising pharmaceuticals
09/26/2013US20130252916 Oramucosal pharmaceutical dosage form
09/26/2013US20130252904 Compositions and methods for treating cancer
09/26/2013US20130252894 Sustained delivery of exenatide and other polypeptides
09/26/2013US20130252893 Novel Composition
09/26/2013US20130252889 Composition comprising vlp and amyloid beta peptide
09/26/2013US20130252306 Methods for increasing protein polyethylene glycol (peg) conjugation
09/26/2013US20130251818 Personal lubricants
09/26/2013US20130251809 Polyamine Derivatives
09/26/2013US20130251806 Natural biocomposite powder prepared from pichia pastoris biomass, method of preparation and its use as excipient
09/26/2013US20130251802 Tamper resistant dosage forms
09/26/2013US20130251801 Tamper resistant dosage forms
09/26/2013US20130251800 Tamper resistant dosage forms
09/26/2013US20130251799 Tamper resistant dosage forms
09/26/2013US20130251798 Tamper resistant dosage forms
09/26/2013US20130251789 Tamper-resistant oral opioid agonist formulations
09/26/2013US20130251784 Method for in vivo targeting of nanoparticles via bioorthogonal copper-free click chemistry
09/26/2013US20130251777 Brachytherapy Seed
09/26/2013US20130251766 Cancer cell targeting using nanoparticles
09/26/2013US20130251764 Methods and compositions for treating tissue using silk proteins
09/26/2013US20130251763 Transdermal compositions
09/26/2013US20130251760 Transdermal Analgesic Systems with Reduced Abuse Potential
09/26/2013US20130251683 Prolonged delivery of heparin-binding growth factors from heparin-derivatized collagen
09/26/2013US20130251676 Anticancer fusion protein
09/26/2013US20130251674 Non-Aqueous Single Phase Vehicles and Formulations Utilizing Such Vehicles
09/26/2013US20130251644 Cyclodextrin-Based Microemulsions, and Dermatological Uses Thereof
09/26/2013US20130251628 Ligands to radiation-induced molecules
09/25/2013EP2641618A2 Humanized anti-CD79B antibodies and immunoconjugates and methods of use
09/25/2013EP2641616A2 Method for in vivo targeting of nanoparticles via bioorthogonal copper-free click chemistry
09/25/2013EP2641615A2 Compositions comprising dietary fat complexer and methods for their use
09/25/2013EP2641614A1 Pharmaceutical preparation integrated with microneedles for skin treatment
09/25/2013EP2641611A2 Combination therapy
09/25/2013EP2641605A1 Novel polymer derivative of cytidine metabolism antagonist
09/25/2013EP2641591A1 Synthesis of Starch Based Bioadhesive Polymers and Applications in Drug Carrier Systems
09/25/2013EP2641590A1 Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
09/25/2013EP2640767A1 Method for preparing amide-initiated polymers having a varied architecture
09/25/2013EP2640424A1 Novel conjugates for targeted drug delivery
09/25/2013EP2640423A1 Lipoyl compounds and their use for treating ischemic injury
09/25/2013EP2640422A1 Polymeric conjugates of active principles, their process of preparation and their polymeric intermediates
09/25/2013EP2640408A2 Keratin compositions for treatment of bone deficiency or injury
09/25/2013EP2640389A1 Transdermal therapeutic system comprising buprenorphine
09/25/2013EP2640370A2 Compositions for transdermal delivery of active agents
09/25/2013EP2640368A1 Controlled release mucoadhesive systems
1 ... 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 ... 1712